Walleye Capital
RAIN

Walleye Capital’s Rain Oncology Inc. Common Stock RAIN Stock Holding History

Walleye Capital’s Portfolio RAIN Stock Details RAIN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-300
Closed -$360 – 5474
2023
Q2 		$360 Buy
+300
New +$1.5K ﹤0.01% 4224

Other funds holding RAIN

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AI
Acuitas Investments Seattle, Washington $1.41M AUM 48.57% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Walleye Capital's RAIN Position: Q3 2023 in Review

Walleye Capital sold out of Rain Oncology Inc. Common Stock (RAIN) in Q3 2023, closing a stake of 20,631 shares — an estimated $24.8K sold.

Walleye Capital first reported a position in RAIN in Q2 2023 and held it in 1 quarter. The position peaked at $24.8K in Q2 2023. 57 funds tracked by Wall St. Rank hold RAIN as of Q3 2023.

  • Walleye Capital reported no remaining Rain Oncology Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Walleye Capital sold 20,631 Rain Oncology Inc. Common Stock shares in Q3 2023, an estimated $24.8K.
  • Walleye Capital first reported a position in Rain Oncology Inc. Common Stock in Q2 2023 and held it in 1 quarter.
  • Walleye Capital's Rain Oncology Inc. Common Stock position peaked at $24.8K in Q2 2023.
  • 57 funds tracked by Wall St. Rank held Rain Oncology Inc. Common Stock as of Q3 2023.

Based on Walleye Capital's 13F filing for Q3 2023, filed 14 Nov 2023.